Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Credo Therapies Ltd
Credo Therapies Ltd is an active company incorporated on 25 October 2022 with the registered office located in Oxford, Oxfordshire. Credo Therapies Ltd was registered 2 years 10 months ago.
Watch Company
Status
Active
Active since
incorporation
Company No
14441022
Private limited company
Age
2 years 10 months
Incorporated
25 October 2022
Size
Micro
Turnover is under
£1M
Under
10 employees
Confirmation
Submitted
Dated
24 October 2024
(10 months ago)
Next confirmation dated
24 October 2025
Due by
7 November 2025
(1 month remaining)
Last change occurred
10 months ago
Accounts
Due Soon
For period
25 Oct
⟶
31 Dec 2023
(1 year 2 months)
Accounts type is
Total Exemption Full
Next accounts for period
31 December 2024
Due by
30 September 2025
(20 days remaining)
Learn more about Credo Therapies Ltd
Contact
Address
8 King Edward Street
Oxford
OX1 4HL
United Kingdom
Address changed on
2 Feb 2024
(1 year 7 months ago)
Previous address was
1 Vincent Square London SW1P 2PN England
Companies in OX1 4HL
Telephone
Unreported
Email
Unreported
Website
Unreported
See All Contacts
People
Officers
6
Shareholders
12
Controllers (PSC)
1
Joel Schoppig
Director • Investor • Swiss • Lives in UK • Born in Aug 1985
Lingyun Shao
Director • Ceo • American • Lives in United States • Born in Aug 1977
Bruce Malcolm Gordon
Director • British • Lives in England • Born in Nov 1959
Dr Rebecca Anne Murphy
Director • Senior Research Clinician • British • Lives in England • Born in Oct 1976
Nicholas Joseph Mercadante
Director • Chief Executive Officer • American • Lives in United States • Born in Aug 1981
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Senechal Ltd
David James Bateman is a mutual person.
Active
Kneu Health Limited
Joel Schoppig is a mutual person.
Active
Capven Limited
David James Bateman is a mutual person.
Dissolved
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2023–2023)
Period Ended
31 Dec 2023
For period
31 Oct
⟶
31 Dec 2023
Traded for
14 months
Cash in Bank
£2.29M
Turnover
Unreported
Employees
10
Total Assets
£2.57M
Total Liabilities
-£38.25K
Net Assets
£2.53M
Debt Ratio (%)
1%
See 10 Year Full Financials
Latest Activity
Mr Bruce Malcolm Gordon Appointed
8 Days Ago on 1 Sep 2025
Oxford Science Enterprises Plc (PSC) Details Changed
4 Months Ago on 12 May 2025
Mr Nicholas Joseph Mercadante Appointed
4 Months Ago on 12 May 2025
David James Bateman Resigned
5 Months Ago on 4 Apr 2025
Confirmation Submitted
10 Months Ago on 6 Nov 2024
Full Accounts Submitted
1 Year 4 Months Ago on 6 May 2024
Liliane Chamas Resigned
1 Year 5 Months Ago on 27 Mar 2024
Joel Schoppig Appointed
1 Year 5 Months Ago on 27 Mar 2024
Cristian Oancea Resigned
1 Year 6 Months Ago on 14 Feb 2024
Registered Address Changed
1 Year 7 Months Ago on 2 Feb 2024
Get Alerts
Get Credit Report
Discover Credo Therapies Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Memorandum and Articles of Association
Submitted on 4 Sep 2025
Resolutions
Submitted on 4 Sep 2025
Appointment of Mr Bruce Malcolm Gordon as a director on 1 September 2025
Submitted on 3 Sep 2025
Termination of appointment of David James Bateman as a director on 4 April 2025
Submitted on 20 Jun 2025
Change of details for Oxford Science Enterprises Plc as a person with significant control on 12 May 2025
Submitted on 9 Jun 2025
Statement of capital following an allotment of shares on 12 May 2025
Submitted on 20 May 2025
Appointment of Mr Nicholas Joseph Mercadante as a director on 12 May 2025
Submitted on 20 May 2025
Change of share class name or designation
Submitted on 20 May 2025
Memorandum and Articles of Association
Submitted on 19 May 2025
Resolutions
Submitted on 19 May 2025
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs